Press Release News courtesy goes to WSJ Article
Adjustment of :
– the Conversion/Exchange Ratio of the bonds convertible into and / or exchangeable for new or existing shares, and
– the Conversion Ratio of the net share settled bonds convertible into new shares and/or exchangeable for existing shares (ORNANE)
PUTEAUX, France–(BUSINESS WIRE)–July 09, 2014–
Regulatory News:
ORPEA (Paris:ORP):
Holders of the bonds convertible into and / or exchangeable for new or existing shares (“Oceanes”) (ISIN code: FR0010973057) and the holders of the net share settled bonds convertible into new shares and/or exchangeable for existing shares (“ORNANE”) (ISIN code: FR0011534874) are informed that, following the Annual general meeting of the shareholders held on June 25, 2014, ORPEA has distributed a dividend of EUR0.70 per ORPEA share (ISIN code: FR0000184798). The dividend ex-date was July 8, 2014.
As a consequence of the payment of such dividend:
— Holders of Oceanes are informed that, pursuant to the terms and
conditions set out in paragraph 4.2.6 of the securities note included in
the prospectus that received from the AMF the visa number 10-429 on
December 7, 2010, the Conversion/Exchange Ratio is adjusted from 1.107 to
1.122 ORPEA share for 1 Oceane, as from July 8, 2014 (calculated to three
decimal places by rounding to the nearest thousandth).
— Holders of ORNANE are informed that, pursuant to the terms and conditions
set out in paragraph 4.16.7 of the securities note included in the
prospectus that received from the AMF the visa number 13-338 on July 9,
2013, the Conversion Ratio is adjusted from 1.017 to 1.031 ORPEA share
for 1 ORNANE, as from July 8, 2014 (calculated to three decimal places by
rounding to the nearest thousandth).
About ORPEA (www.orpea-corp.com)
Listed on Euronext Paris since April 2002 and a member of the Deferred Settlement Service, ORPEA is a European leader in integrated Long-Term Care and Post-Acute Care. The Group had a unique network of 521 healthcare facilities, with 51,259 beds (42,630 of them operational), including:
— 31,871 beds in France at (3,979 beds under refurbishment or construction)
at 345 facilities
— 19,388 beds in the rest of Europe (Germany, Spain, Belgium, Italy and
Switzerland) at 176 facilities (4,650 beds under refurbishment or
construction)
Listed in Euronext Paris Compartment A, a Euronext Group market
Member of the CAC Mid 60, MSCI Small Cap Europe and SBF 120 indices – Member of the SRD
ISIN: FR0000184798- Reuters: ORP.PA – Bloomberg: ORP FP
CONTACT: Investor Relations:
ORPEA
Yves Le Masne
CEO
Steve Grobet
Investor Relations
Tel.: +33 (0)1 47 75 74 66
s.grobet@orpea.net
or
NewCap.
Dusan Oresansky / Emmanuel Huynh
Tel.: +33 (0)1 44 71 94 94
orpea@newcap.fr
SOURCE: ORPEA
Copyright Business Wire 2014
Access Investor Kit for Orpea SA
Visit http://www.companyspotlight.com/partner?cp_code=A591&isin=FR0000184798